Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US7435720B2 · kind B2 · utility
13Cited by
11References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2006 |
| Grant date | Oct 14, 2008 |
| Priority date | — |
| Expiry date | Oct 17, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/183
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and methods are described comprising at least a parathyroid hormone peptide (PTH) preferably PTH1-34 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of PTH, for treating or preventing osteoporosis or osteopenia in a mammalian subject, preferably a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.